Gene Targeting Meets Cell-Based Therapy: Raising the Tail, or Merely a Whimper?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 27836861.
- Also identified by DOI 10.1158/1078-0432.CCR-16-2493 and PMC identifier 5241203.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Appreciation of the immune effects of targeted agents has grown, and efforts to combine these agents with immunotherapy are underway to enhance therapeutic responses. Multiple ongoing trials are examining this concept; however, nuances exist with regard to timing, sequence, and combinatorial strategies. Clin Cancer Res; 23(2); 327-9. ©2016 AACRSee related article by Deniger et al., p. 351.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Gene Targeting
- Immunotherapy
- Neoplasms